Interferon-β can induce progesterone receptors in human endometrial adenocarcinoma

Cancer

Volumn 78, Issue 3, 1996, Pages 448-453

  Codegoni, Anna M ^a   Landoni, Fabio ^b   Lomonico, Sebastiano ^b   Losa, Giuseppe ^b   Mangioni, Costantino ^b   Taverna, Monica ^c   Lucchini, Valeria ^b   D'Incalci, Maurizio ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c Industria Farmaceutica Serono   (Italy)

Author keywords

endometrial adenocarcinoma; estrogen receptors; hIFN ; progesterone receptors

Indexed keywords

BETA INTERFERON; ESTROGEN RECEPTOR; HUMAN INTERFERON; PROGESTERONE RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; INTERFERON INDUCTION; INTRAMUSCULAR DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; INTERFERON-BETA; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0029941261     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960801)78:3<448::AID-CNCR11>3.0.CO;2-Z     Document Type: Article

References (17)

1. McGuire WL, Horwitz KB, Zava DT, Carola RE, Chamness GC. Hormones in breast cancer: update 1978. Metabolism 1978;27:487-501.
2. King RJ. Analysis of estradiol and progesterone receptors in early and advanced breast tumors. Cancer 1980;46:2818-21.
3. Manko A, Heinonen E, Scheinin TM, Tolppanen EM, Vihko R. Oestrogen and progesterone receptors and disease-free interval in primary breast cancer. Br J Cancer 1984;50:667-72.
4. Ehrlich CE, Young PC, Cleary RE. Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications. Am J Obstet Gynecol 1981;141:539-46.
5. Kauppila A. Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations. Acta Obstet Gynecol Scand 1984;63:441-50.
6. Creasman WT, McCarty KSS, Barton TK, McCarty KSJ. Clinical correlates of estrogen- and progesterone-binding proteins in human endometrial adenocarcinoma. Obstet Gynecol 1980;55:363-70.
7. Quinn MA, Pearce P, Fortune DW, Koh SH, Hsieh C, Cauchi M. Correlation between cytoplasmic steroid receptors and tumour differentiation and invasion in endometrial carcinoma. Br J Obstet Gynaecol 1985;92:399-406.
8. Liao BS, Twiggs LB, Leung BS, Yu WC, Polish RA, Prem KA. Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma. Obstet Gynecol 1986;67:463-7.
9. Sica G, Natoli V, Stella C, Del Bianco S. Effect of natural beta-interferon on cell proliferation and steroid receptor level in human breast cancer cells. Cancer 1987;60:2419-23.
10. Pouillart P, Palangie T, Jouve M, Garcia Giralt E, Fridman WH, Magdelenat H, et al. Administration of fibroblast interferon to patients with advanced breast cancer: possible effects on skin metastasis and on hormone receptors. Eur J Cancer Clin Oncol 1982;18:929-35.
11. Sica G, Iacopino F, Lama G, Amadori D, Baroni M, Lo Sardo F, et al. Steroid receptor enhancement by natural interferon-beta in advanced breast cancer. Eur J Cancer 1993;29A:329-33.
12. Angioli R, Untch M, Sevin BU, Steren A, Hightower RD, Perras JP, et al. Enhancement of progesterone receptor levels by interferons in AE-7 endometrial cancer cells. Cancer 1993;71:2776-81.
13. De Cicco F, Sica G, Benedetto MT, Ciabattoni G, Rossiello F, Nicosia A, et al. In vitro effects of beta-interferon on steroid receptors and prostaglandin output in human endometrial adenocarcinoma. J Steroid Biochem 1988;30:359-62.
14. FIGO Stages-1988 revision. Definitions of the clinical stages in carcinoma of the vulva. Gynecol Oncol 1989;35:125-7.
15. Bizzi A, Codegoni AM, Landoni F, Marelli G, Marsoni S, Spina AM, et al. Steroid receptors in epithelial ovarian carcinoma: relation to clinical parameters and survival. Cancer Res 1988;48:6222-6.
16. Lowry OH, Rosenbrough NJ, Farr AL, Randall PJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
17. Sica G, Iacopino F, Lama G, Marchetti P, Carenza L, Dell'Acqua S, et al. Natural interferon-beta treatment and steroid hormone receptors in primary endometrial cancer [published erratum appears in Gynecol Oncol 1994 Feb;52(2): 281]. Gynecol Oncol 1993;50:185-90.